Ruyi Zhang

1.7k total citations
57 papers, 909 citations indexed

About

Ruyi Zhang is a scholar working on Oncology, Molecular Biology and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Ruyi Zhang has authored 57 papers receiving a total of 909 indexed citations (citations by other indexed papers that have themselves been cited), including 19 papers in Oncology, 11 papers in Molecular Biology and 10 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Ruyi Zhang's work include Cancer Immunotherapy and Biomarkers (6 papers), Hepatitis Viruses Studies and Epidemiology (4 papers) and Liver Disease Diagnosis and Treatment (4 papers). Ruyi Zhang is often cited by papers focused on Cancer Immunotherapy and Biomarkers (6 papers), Hepatitis Viruses Studies and Epidemiology (4 papers) and Liver Disease Diagnosis and Treatment (4 papers). Ruyi Zhang collaborates with scholars based in China, Netherlands and United Kingdom. Ruyi Zhang's co-authors include Lan Zhang, Duoxia Xu, Shuai Chen, David Julian McClements, Yahong Han, Fangling Sun, Lin Li, Jin Chu, Cong Shen and Li Lin and has published in prestigious journals such as Journal of Clinical Oncology, PLoS ONE and Diabetes.

In The Last Decade

Ruyi Zhang

53 papers receiving 900 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Ruyi Zhang China 18 307 136 114 91 81 57 909
Jingjing Zhang China 19 369 1.2× 146 1.1× 175 1.5× 81 0.9× 55 0.7× 56 1.1k
Nasrin Maleki‐Dizaji Iran 20 438 1.4× 121 0.9× 117 1.0× 116 1.3× 89 1.1× 45 1.1k
Jia-Hong Chen China 18 325 1.1× 109 0.8× 152 1.3× 106 1.2× 64 0.8× 54 1.0k
Huifeng Hao China 14 354 1.2× 79 0.6× 109 1.0× 132 1.5× 70 0.9× 35 863
Yun‐Ho Kim South Korea 19 310 1.0× 88 0.6× 79 0.7× 124 1.4× 75 0.9× 46 910
Pei‐Ming Chu Taiwan 18 380 1.2× 73 0.5× 76 0.7× 92 1.0× 93 1.1× 31 910
Guofeng Wang China 16 275 0.9× 220 1.6× 166 1.5× 69 0.8× 112 1.4× 42 924
Salunya Tancharoen Thailand 20 296 1.0× 78 0.6× 84 0.7× 133 1.5× 93 1.1× 46 1.1k
Qing Wu China 16 256 0.8× 96 0.7× 137 1.2× 143 1.6× 61 0.8× 37 859
Weiwei Cai China 18 371 1.2× 110 0.8× 62 0.5× 129 1.4× 63 0.8× 47 896

Countries citing papers authored by Ruyi Zhang

Since Specialization
Citations

This map shows the geographic impact of Ruyi Zhang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ruyi Zhang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ruyi Zhang more than expected).

Fields of papers citing papers by Ruyi Zhang

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ruyi Zhang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ruyi Zhang. The network helps show where Ruyi Zhang may publish in the future.

Co-authorship network of co-authors of Ruyi Zhang

This figure shows the co-authorship network connecting the top 25 collaborators of Ruyi Zhang. A scholar is included among the top collaborators of Ruyi Zhang based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ruyi Zhang. Ruyi Zhang is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
Li, Xi, Ruyi Zhang, Xiaogang Xia, et al.. (2025). Tumor Microenvironment-Responsive Nanodrug for Embolotherapy and Enhanced Chemotherapy. ACS Applied Materials & Interfaces. 17(10). 14859–14872. 2 indexed citations
3.
4.
Zhang, Ruyi, Fang Wang, Zhiyu You, et al.. (2024). Approved immune checkpoint inhibitors in hepatocellular carcinoma: a large-scale meta-analysis and systematic review. Journal of Cancer Research and Clinical Oncology. 150(2). 82–82. 2 indexed citations
5.
Lu, Meng, Yumin Zhang, Ya-Wei Guo, et al.. (2024). Platelets promote primary hepatocellular carcinoma metastasis through TGF-β1-mediated cancer cell autophagy. Cancer Letters. 600. 217161–217161. 12 indexed citations
6.
Fan, Xinyue, et al.. (2024). Clinical application of serum CST4 combined with tumor markers in the diagnosis of digestive system malignant tumors. Oncology Letters. 28(2). 384–384. 3 indexed citations
7.
8.
Li, Ning, Ruyi Zhang, Xue Li, et al.. (2022). Quantitative Scintigraphy Evaluated the Relationship between 131I Therapy and Salivary Glands Function in DTC Patients: A Retrospective Analysis. Journal of Healthcare Engineering. 2022. 1–13. 2 indexed citations
9.
Zhang, Ruyi, Yahong Han, David Julian McClements, Duoxia Xu, & Shuai Chen. (2022). Production, Characterization, Delivery, and Cholesterol-Lowering Mechanism of Phytosterols: A Review. Journal of Agricultural and Food Chemistry. 70(8). 2483–2494. 93 indexed citations
10.
Chen, Dong, Xuanwen Bao, Ruyi Zhang, et al.. (2021). Depiction of the genomic and genetic landscape identifies CCL5 as a protective factor in colorectal neuroendocrine carcinoma. British Journal of Cancer. 125(7). 994–1002. 21 indexed citations
11.
Miao, Zhijiang, Ruyi Zhang, Peifa Yu, et al.. (2021). The macrolide antibiotic azithromycin potently inhibits hepatitis E virus in cell culture models. International Journal of Antimicrobial Agents. 58(3). 106383–106383. 6 indexed citations
12.
Zhang, Hua, et al.. (2021). Immune Characters and Plasticity of the Sentinel Lymph Node in Colorectal Cancer Patients. Journal of Immunology Research. 2021. 1–11. 5 indexed citations
13.
Hu, Xiumei, Chang-Meng Wu, Bo Situ, et al.. (2021). EDTA-K2 Improves the Detection Sensitivity of SARS-CoV-2 IgM and IgG Antibodies by Chelating Colloidal Gold in the Immunochromatographic Assay. International Journal of Nanomedicine. Volume 16. 715–724. 14 indexed citations
14.
Zhang, Ruyi, Marco Puzzoni, Stefano Mariani, et al.. (2021). Emerging treatment evolutions and integrated molecular characteristics of biliary tract cancers. Cancer Science. 112(12). 4819–4833. 6 indexed citations
15.
Cui, Yuan, Hao‐Long Zhou, Muhong Wei, et al.. (2021). Multiple vitamin co-exposure and mortality risk: A prospective study. Clinical Nutrition. 41(2). 337–347. 16 indexed citations
16.
Guan, Xumin, He Zhang, Qian Wang, et al.. (2020). Transplantation of human induced pluripotent stem cell-derived cardiomyocytes improves myocardial function and reverses ventricular remodeling in infarcted rat hearts. Stem Cell Research & Therapy. 11(1). 201–201. 58 indexed citations
17.
18.
Zhang, Ruyi, Jiao Wang, Jinhua Luo, et al.. (2015). Cutoff value of HbA1c for predicting diabetes and prediabetes in a Chinese high risk population aged over 45.. PubMed. 24(3). 360–6. 1 indexed citations
19.
Zhang, Ruyi, Chunli Li, Xue Yin, et al.. (2015). Dexmedetomidine attenuates acute lung injury induced by lipopolysaccharide in mouse through inhibition of MAPK pathway. Fundamental and Clinical Pharmacology. 29(5). 462–471. 32 indexed citations
20.
Zhang, Ruyi, et al.. (1996). The constituents from the rhizoma of Alisma orientalis (Sam) Juzep.. Tianran chanwu yanjiu yu kaifa. 8(1). 5–9. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Jingjing Zhang Breakdown of academic impact, for papers by Nasrin Maleki‐Dizaji Breakdown of academic impact, for papers by Jia-Hong Chen Breakdown of academic impact, for papers by Huifeng Hao Breakdown of academic impact, for papers by Yun‐Ho Kim Breakdown of academic impact, for papers by Pei‐Ming Chu Breakdown of academic impact, for papers by Guofeng Wang Breakdown of academic impact, for papers by Salunya Tancharoen Breakdown of academic impact, for papers by Qing Wu Breakdown of academic impact, for papers by Weiwei Cai
Rankless by CCL
2026